Skip Navigation


Cardiovascular Research Advance Access originally published online on September 19, 2007
Cardiovascular Research 2008 77(2):353-361; doi:10.1093/cvr/cvm018
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
77/2/353    most recent
cvm018v2
cvm018v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kohr, M. J.
Right arrow Articles by Ziolo, M. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kohr, M. J.
Right arrow Articles by Ziolo, M. T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2007. For Permissions please e-mail: journals.permissions@oxfordjournals.org

Targeting of phospholamban by peroxynitrite decreases β-adrenergic stimulation in cardiomyocytes

Mark J. Kohr1, Honglan Wang1, Debra G. Wheeler1, Murugesan Velayutham2, Jay L. Zweier2 and Mark T. Ziolo1,*

1 Department of Physiology and Cell Biology, Davis Heart and Lung Research Institute, The Ohio State University, 304 Hamilton Hall, 1645 Neil Avenue, Columbus, OH 43210, USA
2 Department of Internal Medicine, Division of Cardiovascular Medicine, Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210, USA

* Corresponding author. Tel: +1 614 688 7905; fax: +1 614 688 7999. E-mail address: ziolo.1{at}osu.edu

Aims: Peroxynitrite production increases during the pathogenesis of numerous cardiac disorders (e.g. heart failure). However, limited studies have investigated the mechanism through which peroxynitrite exerts anti-adrenergic effects. Thus, the purpose of this study is to investigate the contribution of phospholamban (PLB), a critical excitation–contraction coupling protein, to the peroxynitrite-induced dysfunction.

Methods and results: Isolated myocytes from wild-type (WT, CF-1) and PLB knockout (PLB–/–) mice were stimulated at 1 Hz, and myocyte shortening and Ca2+ transients were simultaneously recorded. PLB phosphorylation was measured via western blot. Myocytes were superfused with isoproterenol, a β-adrenergic agonist, and SIN-1, a peroxynitrite donor. SIN-1 superfusion dramatically decreased isoproterenol-stimulated Ca2+ transients and myocyte shortening in WT myocytes. These effects were inhibited upon addition of the peroxynitrite decomposition catalyst, FeTPPS. Surprisingly, SIN-1 had no functional effect on β-adrenergic-stimulated PLB–/– myocytes. Western blot analyses revealed that SIN-1 significantly decreased isoproterenol-stimulated PLBSer16 phosphorylation. Experiments with the protein phosphatase inhibitor, okadaic acid, alleviated the SIN-1-induced functional effects and the decrease in PLB phosphorylation.

Conclusions: The peroxynitrite donor SIN-1 decreases β-adrenergic stimulation by reducing PLBSer16 phosphorylation via protein phosphatase activation. This peroxynitrite-induced decrease in PLB phosphorylation may be a key mechanism in the β-adrenergic dysfunction observed in many cardiomyopathies.

KEYWORDS E-C coupling; SR Function; Calcium (cellular); Protein Phosphorylation; Protein Phosphatases


Time for primary review: 27 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Wang, M. J. Kohr, D. G. Wheeler, and M. T. Ziolo
Endothelial nitric oxide synthase decreases {beta}-adrenergic responsiveness via inhibition of the L-type Ca2+ current
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1473 - H1480.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Garcia-Dorado, H. M. Piper, and D. A. Eisner
Sarcoplasmic reticulum and mitochondria in cardiac pathophysiology
Cardiovasc Res, January 15, 2008; 77(2): 231 - 233.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.